[CHEMOTHERAPY OF UTERINE CERVIX CARCINOMA].
D000970:Antineoplastic Agents; D001375:Azaguanine; D001388:Aziridines; D010478:Chemotherapy, Cancer, Regional Perfusion; D003520:Cyclophosphamide; D005260:Female; D005472:Fluorouracil; D006801:Humans; D007263:Infusions, Parenteral; D008558:Melphalan; D008727:Methotrexate; D009369:Neoplasms / Q000628:therapy*; D009588:Nitrogen Mustard Compounds; D014228:Triaziquone; D014499:Uracil Mustard; D002583:Uterine Cervical Neoplasms; D014747:Vinblastine
D000970:Antineoplastic Agents; D001388:Aziridines; D009588:Nitrogen Mustard Compounds; D014747:Vinblastine; D003520:Cyclophosphamide; C026480:inproquone; D014228:Triaziquone; D001375:Azaguanine; D008558:Melphalan; D005472:Fluorouracil; D014499:Uracil Mustard; D008727:Methotrexate
ANTINEOPLASTIC AGENTS; AZAGUANINE; BAYER E39; CERVIX NEOPLASMS; CYCLOPHOSPHAMIDE; FLUOROURACIL; INFUSIONS, PARENTERAL; ISOLATION PERFUSION; MELPHALAN; METHOTREXATE; NEOPLASM THERAPY; NITROGEN MUSTARD COMPOUNDS; REVIEW; TRIAZIQUONE; URACIL MUSTARD; VINBLASTINE
CHEMIOTERAPIA DEL CERVICOCARCINOMA UTERINO.